Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination

Veterinary Immunology and Immunopathology

Volumn 111, Issue 1-2, 2006, Pages 47-57

  Minke, J M ^a   Fischer, L ^a   Baudu, Ph ^a   Guigal, P M ^a   Sindle, T ^b   Mumford, J A ^b   Audonnet, J C ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Canarypox vector; DNA vaccination; EHV 1; Vaccination

Indexed keywords

ALUMINUM PHOSPHATE; CARBOMER; GLYCOPROTEIN B; GLYCOPROTEIN D; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLASMID DNA; PROTEIN C; RECOMBINANT DNA; RECOMBINANT VACCINE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CANARYPOX VIRUS; CLINICAL OBSERVATION; CONTROLLED STUDY; EQUINE HERPES VIRUS; FEMALE; HORSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOREACTIVITY; NONHUMAN; RESPIRATORY TRACT DISEASE; SEROLOGY; VACCINATION; VIREMIA; VIROLOGY; VIRUS EXCRETION; VIRUS INFECTION; VIRUS STRAIN; VIRUS VIRULENCE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HERPESVIRUS VACCINES; HORSE DISEASES; HORSES; MALE; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ANIMALIA; CANARYPOX VIRUS; EQUID HERPESVIRUS 1; EQUIDAE; EQUUS CABALLUS;

EID: 33646497033     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.01.008     Document Type: Article

References (24)

1. Allen G.P., and Bryans J.T. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpes virus-1 infections. Prog. Vet. Microbiol. Immunol. 2 (1986) 78-144
2. Allen G.P., Coogle L.D., Ostlund E.N., and Yeargan M.R. Molecular dissection of two major equine herpes virus-1 glycoprotein antigens (gB and gC) that elicit humoral-immune responses in the horse. In: Plowright W., Rossdale P.D., and Wade J.F. (Eds). Equine Infectious Diseases vol. VI (1991), R&W Publications Ltd., Newmarket, UK 181-192
3. Allen G.P., Kydd J.H., Slater J.D., and Smith K.C. Advances in understanding of the pathogenesis, epidemiology, and immunological control of equine herpes virus abortion. In: Wernery U., Wade J.F., Mumford J.A., and Kaaden O.R. (Eds). Equine Infectious Diseases vol. VIII (1998), R&W Publications Ltd., Newmarket, UK 129-146
4. Crabb B.S., MacPherson C.M., Reubel G.H., Browning G.F., Studdert M.J., and Drummer H.E. A type-specific serological test to distinguish antibodies to equine herpes viruses 4 and 1. Arch. Virol. 140 (1995) 245-258
5. Fischer L., Minke J., Dufay N., Baudu Ph., and Audonnet J.C. Rabies DNA vaccine in the horse: strategies to improve serological responses. Vaccine 21 (2003) 4593-4596
6. Gilkerson J.R., Whalley J.M., Drummer H.E., Studdert M.J., and Love D.N. Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on the Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foals?. Vet. Microbiol. 68 (1999) 27-34
7. Hartikka J., Sawdey M., Cornefert-Jensen F., Margalith M., Barnhart K., Nolasco M., Lee Vahlsing H., Meek J., Marquet M., Hobart P., Norman J., and Manthorpe M. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum. Gene. Ther. 7 (1996) 1205-1217
8. Konishi E., Yamaoka M., Khin-Sane-Win, Kurane I., Takada K., and Mason P.W. The anamnestic neutralising antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus pre-membrane and envelope genes. J. Virol. 73 (1999) 5527-5534
9. Kydd J.H., Wattrang E., and Hannant D. Pre-infection frequencies of equine herpes virus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet. Immunol. Immunopathol. 96 (2003) 207-217
10. Matsumura T., Sugiura T., Imagawa H., Fukunaga Y., and Kamada M. Epizootiological aspects of type 1 and type 4 equine herpes virus infections among horse populations. J. Vet. Med. Sci. 54 (1992) 207-211
11. Minke J.M., Audonnet J.C., Jessett D.M., Fischer L., Guigal P.M., Coupier H., Pardo M.C., Taylor J., Tartaglia J., and Mumford J.A. Canarypox as a vector for influenza and EHV-1 genes: challenges and rewards. Proceedings of the 2nd International Veterinary Vaccines and Diagontic Conference. Oxford (2000) 36
12. Minke J.M., Siger L., Karaca K., Augsten L., Gordy P., Bowen R., Renshaw R.W., Loosmore S., Audonnet J.C., and Nordgren B. Recombinant canarypox virus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch. Virol. Suppl. 18 (2004) 221-230
13. Minke J.M., Audonnet J.A., and Fischer L. Equine viral vaccines: the past, present and future. Vet. Res. 35 (2004) 425-443
14. Mumford J.A., Hannant D., Jessett D.M., O'Neill T.O., Smith K.C., and Ostlund E.N. Abortigenic and neurological disease caused by experimental infection with equid herpes virus-1. In: Nakajima H., and Plowright W. (Eds). Equine Infectious Diseases vol. VII (1994), R&W Publications Ltd., Newmarket, UK 261-275
15. Osterrieder N., Kaaden O.R., and Neubauer A. Structure and function of equine herpes virus glycoproteins-a review. In: Wernery U., Wade J.F., Mumford J.A., and Kaaden O.R. (Eds). Equine Infectious Diseases vol. VIII (1998), R&W Publications Ltd., Newmarket, UK 111-118
16. Otten G.R., Dor B., and Schaefer M. Relative potency of cellular and humoral immune responses induced by DNA vaccination. Intervirology 43 (2000) 227-232
17. Patel J.R., Földi J., Bateman H., Williams J., Didlick S., and Stark R. Equid herpes virus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV type 1 and 4 challenge. Vet. Microbiol. 92 (2003) 1-17
18. Soboll G., Whalley J.M., Koen M.T., Allen G.P., Fraser D.G., Macklin M.D., Swain W.F., and Lunn P. Identification of equine herpes virus-1 antigens recognized by cytotoxic T lymphocytes. J. Gen. Virol. 84 (2003) 2625-2634
19. Somasundam C., Takamatsu H., Andréoni C., Audonet J.C., Fischer L., Lefèvre F., and Charley B. Enhanced protective response and immuno-adjuvant effect of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus. Vet. Immunol. Immunopathol. 70 (1999) 277-287
20. Studdert M.J., Simpson T., and Roizman B. Differentiation of respiratory and abortigenic isolates of equine herpes virus-1 by restriction endonucleases. Science 214 (1986) 562-564
21. Thompson G.R., Mumford J.A., and Smith I.M. Experimental immunization against respiratory disease due to equid herpes virus-1 infection (rhinopneumonitis) using formalin-inactivated virus with various adjuvants. Vet. Microbiol. 4 (1979) 209-222
22. Thomson G.R., Mumford J.A., Campbell J., Griffith L., and Clapham P. Serological detection of equid herpes virus-1 infections of the respiratory tract. Equine Vet. J. 8 (1976) 58-65
23. Ulmer J.B., DeWitt C.M., Chastain M., Friedman A., Donnelly J.J., McClements W.L., Caulfield M.J., Bohannon K.E., Volkin D.B., and Evans R.K. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine 18 (1999) 18-28
24. Van Maanen C. Equine herpes virus-1 and 4 infections: an update. Vet. Q. 24 2 (2002) 57-78